Vnitr Lek 1985, 31(9):887-893
[Determination of leucine arylamidase (LAS) activity in the urine during the monitoring of cisplatin nephrotoxicity in oncologic diseases].
Klíčová slova: Cisplatin, adverse effects, ; Humans; Kidney, drug effects, ; Leucyl Aminopeptidase, urine, ; Neoplasms, drug therapy,
Keywords: Cisplatin /adverse effects/; Humans; Kidney /drug effects/; Leucyl Aminopeptidase /urine/; Neoplasms /drug therapy/
Zveřejněno: 1. září 1985 Zobrazit citaci
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |